30 likes | 41 Views
Wearable Injectors Market size was valued at USD 6.66 billion in 2021 and is poised to grow from USD 7.65 billion in 2022 to USD 23.89 billion by 2030, growing at a CAGR of 15.29% in the forecast period (2023-2030).<br><br>
E N D
Global Wearable Injectors Market Size, Share, Growth Analysis, By Type, By Therapy - Industry Forecast 2023-2030 Wearable Injectors Market size was valued at USD 6.66 billion in 2021 and is poised to grow from USD 7.65 billion in 2022 to USD 23.89 billion by 2030, growing at a CAGR of 15.29% in the forecast period (2023-2030). Wearable injectors are delivery methods that stick to the skin and allow for long- term subcutaneous drug administration. The equipment in wearable injectors gives more accurate dosing, along with other clinical advantages, and higher delivery precision. The components of any wearable injector are the same: a reservoir for medication, a cannula for tissue supply, an adhesion to secure the equipment to the skin's surface, and a driving mechanism to provide the right amount of medication. Comparing wearable injectors to traditional injecting techniques, they are a more affordable form of administration. The market for wearable injectors is expected to develop as a result of the advantages these devices have over traditional injections, including better drug dose and time control, enhanced patient ease and satisfaction, and a decrease in methodological problems. But throughout the projected timeline, unfavorable reimbursement rules are expected to slow the rising demand for wearable injectors. Wearable Injectors Market Analysis by Type
In 2021, the on-body market category held the highest market share. Particularly on the stomach, these feel comfortable against the body. In-home care settings can also utilize them easily because they are waterproof. Additionally, it is predicted that the segment would develop faster in the years to come due to an increase in the market for home care. However, the prediction predicts that off-body injectors will increase the most in the coming few years. Off-body injectors have gained popularity as a result of the drawbacks of on-body injectors, such as unpleasant withdrawal, contact dermatitis and irritation, and problems with adhesive compatibility. Wearable Injectors Market Analysis by Therapy The wearable injectors market saw a major revenue share in the Cardiovascular diseases category in 2021. The global increase in the prevalence of sedentary lifestyles is blamed for the sector's continuous rise. Heart and blood vascular issues are grouped together as CVDs. A blockage that prevents blood from getting to the heart or brain usually results in abrupt events like heart attacks and strokes. The most frequent cause is an accumulation of fatty deposits on the inside lining of the blood vessels that supply the heart/brain. View more info: https://www.skyquestt.com/report/wearable-injectors-market Top Players in the Global Wearable Injector Market Becton, Dickinson and Company (BD) • Bespak Europe Ltd. • CeQur SA • Debiotech SA • Enable Injections • Insulet Corporation • About Us: SkyQuest Technology is leading growth consulting firm providing market
intelligence, commercialization and technology services. It has 450+ happy clients globally. Address: 1 Apache Way, Westford, Massachusetts 01886 Phone: USA (+1) 617-230-0741 Email: sales@skyquestt.com LinkedIn Facebook Twitter